Kfar Sava, 
  • Booth: 622

Taking Care of your Herd

Armenta Ltd., an Agtech company, is developing innovative therapies to transform the standard of care for dairy cattle diseases. Our first target indication, mastitis, is a significant economic burden on dairy farms. It reduces milk yield and quality and increases culling rates, causing more than $2B in lost annual revenue in the U.S. and more than $1.5B in the E.U.

Armenta’s APT-based solution offers increased milk yield after calving, profitability throughout the lactation period, reduced impact of Mastitis on milk yield & quality, udder protection during the dry period and increased milk yield in the next lactation.

Armenta’s APT-based solution shown to produce new blood vessels, reduce inflammation and improve tissue functioning with positive long-term effects.

Armenta aims to dramatically reduce the monetary losses from these pathologies, with the focus on a non-antibiotic mastitis therapy.

For Technical Support with this webpage, please contact support